Usefulness of procalcitonin for severity assessment in patients with acute cholangitis

Clinical Laboratory

Volumn 59, Issue 1-2, 2013, Pages 177-183

  Hamano, Kosei ^a   Noguchi, Osamu ^a   Matsumoto, Yuka ^a   Watabe, Taro ^a   Numata, Mariko ^a   Yosioka, Atsusi ^a   Ito, Yumi ^a   Hosoi, Hiroko ^a  

^a Ohme Municipal General Hospital   (Japan)

Author keywords

Acute cholangitis; Procalcitonin; Receiver operating characteristic curve

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ACUTE CHOLANGITIS; ACUTE DISEASE; ADULT; AGED; ARTICLE; CHOLANGITIS; DISEASE SEVERITY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CHOLANGITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84874588927     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120520     Document Type: Article

References (36)

1. Reynolds BM, Dargan EL. Acute obstructive cholangitis; a distinct clinical syndrome. Ann Surg 1959;150:299-303.
2. Lai EC, Mok FP, Tan ES, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992;326:1582-6.
3. Pitt HA, Postier RG, Cameron JL. Consequences of preoperative cholangitis and its treatment on the outcome of operation for choledocholithiasis. Surgery 1983;94:447-52. (Pubitemid 13007948)
4. Gigot JF, Leese T, Dereme T, et al. Acute cholangitis. Multivariate analysis of risk factors. Ann Surg 1989;209:435-8. (Pubitemid 19106274)
5. O'Connor HJ, Vickers CR, Buckels JA, et al. Role of endoscopic retrograde cholangiopancreatography after orthotopic liver transplantation. Gut 1991;32:419-23.
6. Thompson JE Jr, Pitt HA, Doty JE, Coleman J, Irving C. Broad spectrum penicillin as an adequate therapy for acute cholangitis. Surg Gynecol Obstet 1990;171:275-82. (Pubitemid 20383514)
7. Liu TJ. Acute biliary septic shock. HPB Surg 1990;2:177-83.
8. Lai EC, Tam PC, Paterson IA, et al. Emergency surgery or severe acute cholangitis. The high-risk patients. Ann Surg 1990;211:55-9. (Pubitemid 20027883)
9. Csendes A, Diaz JC, Burdiles P, Maluenda F, Morales E. Risk factors and classification of acute suppurative cholangitis. Br J Surg 1992;79(7):655-8.
10. Kimmings AN, van Deventer SJ, Rauws EAJ, Huibregtse K, Gouma DJ. Systemic inflammatory response in acute cholangitis and after subsequent treatment. Eur J Surg 2000;166:700-5.
11. Gong JP, Liu CA, Wu CX, et al. Nuclear factor κB activity in patients with acute severe cholangitis. World J Gastroenterol 2002;8:346-9.
12. Committee on Guidelines for the Management of Acute Cholangitis. Guidelines for the Management of Acute Cholangitis/ Cholecystitis. 1st edn. Tokyo: Igaku Tosho Shuppan, 2005.
13. Takada T, Kawarada Y, Nimura Y, et al. Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg 2007;14:1-10. (Pubitemid 46189136)
14. Wada K, Takada T, Kawarada Y, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007;14:52-8. (Pubitemid 46189142)
15. Mayumi T, Takada T, Kawarada Y, et al. Results of the Tokyo Consensus Meeting Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007;14:114-21. (Pubitemid 46189149)
16. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8. (Pubitemid 23066085)
17. Davis TM, Assicot M, Bohuon C, et al. Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 1994;88:670-1.
18. Becker KL, Nylén ES, White JC, Müller B, Snider RH Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89:1512-25. (Pubitemid 38507896)
19. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7. (Pubitemid 46274517)
20. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008;36:941-52.
21. Nylen ES, O'Neill W, Jordan MH, et al. Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 1992;24:439-43.
22. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8. (Pubitemid 23066085)
23. Kapetanos D, Christodoulou D, Fitili CH, et al. The value of serum procalcitonin in the early phase of post-ERCP pancreatitis. Ann Gastroenterol 2010:23:195-99.
24. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-93.
25. Welch JP, Donaldson GA. The urgency of diagnosis and surgical treatment of acute suppurative cholangitis. Am J Surg 1976;131:527-32.
26. Sung JJ, Lyon DJ, Suen R, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial. J Antimicrob Chemother 1995;35:855-64.
27. Leung JW, Chung SC, Sung JJ, Banez VP, Li AK. Urgent endoscopic drainage for acute suppurative cholangitis. Lancet 1989;1:1307-9. (Pubitemid 19151910)
28. Kylänpää-Bäck ML, Takala A, Kemppainen E, et al. Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2001;88:222-7. (Pubitemid 32142709)
29. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-8.
30. Jensen JU, Heslet L, Jensen TH, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34:2596-602. (Pubitemid 44413058)
31. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-17. Erratum in: Clin Infect Dis 2005;40:1386-8. (Pubitemid 38971491)
32. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analy-sis. Crit Care Med 2006;34:1996-2003. (Pubitemid 43982479)
33. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7:210-7. (Pubitemid 46274517)
34. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-7. (Pubitemid 38264177)
35. Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007;131:9-19. (Pubitemid 46122969)
36. Bouadma L, Luyt CE, Tubach F, et al. PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375:463-74.